WO2007132134A3 - Compositions comprenant au moins un dérivé de l'acide naphtoïque et du péroxyde de benzoyle, leurs procédés de préparation, et leurs utilisations - Google Patents

Compositions comprenant au moins un dérivé de l'acide naphtoïque et du péroxyde de benzoyle, leurs procédés de préparation, et leurs utilisations Download PDF

Info

Publication number
WO2007132134A3
WO2007132134A3 PCT/FR2007/051296 FR2007051296W WO2007132134A3 WO 2007132134 A3 WO2007132134 A3 WO 2007132134A3 FR 2007051296 W FR2007051296 W FR 2007051296W WO 2007132134 A3 WO2007132134 A3 WO 2007132134A3
Authority
WO
WIPO (PCT)
Prior art keywords
acid derivative
benzoyl peroxide
naphthoic acid
compositions
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/FR2007/051296
Other languages
English (en)
Other versions
WO2007132134A2 (fr
Inventor
Laurent Fredon
Nathalie Willcox
Sandrine Segura-Orsoni
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Galderma Research and Development SNC
Original Assignee
Galderma Research and Development SNC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galderma Research and Development SNC filed Critical Galderma Research and Development SNC
Priority to EP07766070A priority Critical patent/EP2019663A2/fr
Priority to CA002649124A priority patent/CA2649124A1/fr
Publication of WO2007132134A2 publication Critical patent/WO2007132134A2/fr
Publication of WO2007132134A3 publication Critical patent/WO2007132134A3/fr
Priority to US12/272,061 priority patent/US20090191245A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)

Abstract

L'invention concerne une composition pour application topique 5 comprenant, dans un milieu physiologiquement acceptable, au moins un dérivé de l'acide naphtoïque et du peroxyde de benzoyle sous forme encapsulée. L'invention s'applique en particulier en pharmacie humaine ou en cosmétique.
PCT/FR2007/051296 2006-05-17 2007-05-16 Compositions comprenant au moins un dérivé de l'acide naphtoïque et du péroxyde de benzoyle, leurs procédés de préparation, et leurs utilisations Ceased WO2007132134A2 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
EP07766070A EP2019663A2 (fr) 2006-05-17 2007-05-16 Compositions comprenant au moins un dérivé de l'acide naphtoïque et du péroxyde de benzoyle, leurs procédés de préparation, et leurs utilisations
CA002649124A CA2649124A1 (fr) 2006-05-17 2007-05-16 Compositions comprenant au moins un derive de l'acide naphtoique et du peroxyde de benzoyle, leurs procedes de preparation, et leurs utilisations
US12/272,061 US20090191245A1 (en) 2006-05-17 2008-11-17 Reduced-irritant dermatological compositions comprising at least one naphthoic acid compound and benzoyl peroxide and treatment of keratinization disorders therewith

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0604407A FR2901139B1 (fr) 2006-05-17 2006-05-17 Compositions comprenant au moins un derive de l'acide naphtoique et du peroxyde de benzoyle, leurs procedes de preparation, et leurs utilisations
FR0604407 2006-05-17

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US12/272,061 Continuation US20090191245A1 (en) 2006-05-17 2008-11-17 Reduced-irritant dermatological compositions comprising at least one naphthoic acid compound and benzoyl peroxide and treatment of keratinization disorders therewith

Publications (2)

Publication Number Publication Date
WO2007132134A2 WO2007132134A2 (fr) 2007-11-22
WO2007132134A3 true WO2007132134A3 (fr) 2008-01-10

Family

ID=37561252

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR2007/051296 Ceased WO2007132134A2 (fr) 2006-05-17 2007-05-16 Compositions comprenant au moins un dérivé de l'acide naphtoïque et du péroxyde de benzoyle, leurs procédés de préparation, et leurs utilisations

Country Status (5)

Country Link
US (1) US20090191245A1 (fr)
EP (1) EP2019663A2 (fr)
CA (1) CA2649124A1 (fr)
FR (1) FR2901139B1 (fr)
WO (1) WO2007132134A2 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8936800B2 (en) 2001-12-21 2015-01-20 Galderma Research & Development Gel composition for treatment of common acne comprising a combination of benzoyl peroxide and adapalene and/or adapalene salt

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2903603B1 (fr) * 2006-07-13 2009-03-20 Galderma Res & Dev S N C Snc Combinaison d'adapalene et de peroxyde de benzole dans le traitement de l'acne
US8080537B2 (en) 2006-07-13 2011-12-20 Galderma Research & Development Combinations of adapalene and benzoyl peroxide for treating acne lesions
FR2910320B1 (fr) 2006-12-21 2009-02-13 Galderma Res & Dev S N C Snc Emulsion comprenant au moins un retinoide et du peroxyde de benzole
FR2910321B1 (fr) 2006-12-21 2009-07-10 Galderma Res & Dev S N C Snc Gel creme comprenant au moins un retinoide et du peroxyde de benzole
FR2916966B1 (fr) * 2007-06-11 2011-01-14 Galderma Res & Dev Compositions comprenant au moins un compose retinoide, un compose anti-irritant et du peroxyde de benzoyle, et leurs utilisations
FR2916975B1 (fr) * 2007-06-11 2009-09-04 Galderma Res & Dev Compositions comprenant au moins un compose retinoide, un compose anti-irritant et du peroxyde de benzoyle, et leurs utilisations
CN102686208A (zh) * 2009-10-07 2012-09-19 塔格拉生物科技有限公司 包含过氧化苯甲酰的微胶囊和包含所述微胶囊的局部用组合物
JP5784619B2 (ja) * 2009-10-21 2015-09-24 ドウ ファーマシューティカル サイエンシーズ、インク． 過酸化ベンゾイルを含む粉末を湿潤させるための方法
US9744150B2 (en) * 2009-10-21 2017-08-29 Dow Pharmaceutical Sciences Inc. Suspension containing micronized benzoyl peroxide
BR112016022743A2 (pt) * 2014-04-01 2017-08-15 Galderma Res & Dev Método para tratar e/ou evitar pelo menos uma cicatriz de acne, uso de uma combinação fixa de adapaleno e peróxido de benzoíla e composição
WO2017068673A1 (fr) * 2015-10-21 2017-04-27 マルホ株式会社 Composition pharmaceutique pour la peau

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0375520A1 (fr) * 1988-12-20 1990-06-27 Centre International De Recherches Dermatologiques Galderma - Cird Galderma Composition cosmétique ou pharmaceutique contenant des microsphères de polymères ou de corps gras chargées d'au moins un produit actif
US5879716A (en) * 1985-12-18 1999-03-09 Advanced Polymer Systems, Inc. Methods and compositions for topical delivery of benzoyl peroxide
WO2003055472A1 (fr) * 2001-12-21 2003-07-10 Galderma Research & Development, Snc Gel comprenant au moins un retinoide et du peroxyde de benzoyle

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7820186B2 (en) * 2001-12-21 2010-10-26 Galderma Research & Development Gel composition for once-daily treatment of common acne comprising a combination of benzoyl peroxide and adapalene and/or adapalene salt

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5879716A (en) * 1985-12-18 1999-03-09 Advanced Polymer Systems, Inc. Methods and compositions for topical delivery of benzoyl peroxide
EP0375520A1 (fr) * 1988-12-20 1990-06-27 Centre International De Recherches Dermatologiques Galderma - Cird Galderma Composition cosmétique ou pharmaceutique contenant des microsphères de polymères ou de corps gras chargées d'au moins un produit actif
WO2003055472A1 (fr) * 2001-12-21 2003-07-10 Galderma Research & Development, Snc Gel comprenant au moins un retinoide et du peroxyde de benzoyle

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
EMBIL K ET AL: "THE MICROSPONGE DELIVERY SYSTEM (MDS): A TOPICAL DELIVERY SYSTEM WITH REDUCED IRRITANCY INCORPORATING MULTIPLE TRIGGERING MECHANISMS FOR THE RELEASE OF ACTIVES", JOURNAL OF MICROENCAPSULATION, TAYLOR AND FRANCIS, BASINGSTOKE, GB, vol. 13, no. 5, 1 September 1996 (1996-09-01), pages 575 - 588, XP000599288, ISSN: 0265-2048 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8936800B2 (en) 2001-12-21 2015-01-20 Galderma Research & Development Gel composition for treatment of common acne comprising a combination of benzoyl peroxide and adapalene and/or adapalene salt

Also Published As

Publication number Publication date
WO2007132134A2 (fr) 2007-11-22
CA2649124A1 (fr) 2007-11-22
FR2901139A1 (fr) 2007-11-23
US20090191245A1 (en) 2009-07-30
EP2019663A2 (fr) 2009-02-04
FR2901139B1 (fr) 2009-03-20

Similar Documents

Publication Publication Date Title
WO2007132134A3 (fr) Compositions comprenant au moins un dérivé de l'acide naphtoïque et du péroxyde de benzoyle, leurs procédés de préparation, et leurs utilisations
WO2009074735A8 (fr) Utilisation d'un nouvel agent naturel dans des compositions cosmetiques
WO2008087354A3 (fr) Gel creme comprenant au moins un retinoide et du péroxyde de benzoyle
WO2009077693A3 (fr) Compositions comprenant au moins un derive de l'acide naphtoique, du peroxyde de benzoyle et au moins un agent filmogene
WO2011073437A3 (fr) Compositions cosmétiques ou dermatologiques à base de bactériocines et de prébiotiques
EP2168570A3 (fr) Extraits d'isochrysis sp.
GB2431876B (en) Use of para-coumaric acid or para-hydroxycinnamic acid derivatives in cosmetic or dermatological compositions
MX2009005308A (es) Composiciones que comprenden peroxido de benzoilo, al menos un derivado del acido naftoico y al menos un compuesto del tipo polimeros de poliuretano o derivados de estos y sus usos.
WO2008087348A3 (fr) Emulsion comprenant au moins un retinoide et du péroxyde de benzoyle
WO2007098128A3 (fr) Formules liquides de phényléphrine
NZ596254A (en) Cleanser compositions and methods for using the same comprising linalool, hinokitiol, diol and surfactant
WO2011148328A3 (fr) Procédé cosmétique pour le maquillage et/ou le soin de la peau et/ou des lèvres
WO2006119283A3 (fr) Compositions anti-odeurs et utilisation therapeutique associee
WO2009004629A3 (fr) Procédé pour réduire les symptômes de consommation d'alcool
WO2009141541A3 (fr) Utilisation d' inhibiteurs de kif13a et d ' ap-1 pour inhiber la melanogenese
WO2008086457A3 (fr) Compositions d'hygiène bucco-dentaire contenant un extrait d'hippophae
WO2008139123A3 (fr) Preparations pharmaceutiques ou cosmetiques pour application topique et/ou parenterale, leurs procedes de preparation, et leurs utilisations
WO2011039444A3 (fr) Composition, utilisation et procédé de conservation
EP1874298A4 (fr) Procedes et compositions de production, formulation et utilisation de 1-aryl-3-azabicyclo[3,1,0]hexanes
WO2007038621A3 (fr) Compositions d'aliments enrobees et procedes de preparation correspondants
WO2009138702A3 (fr) Utilisation cosmetique d'un actif issu d'ophiopogon japonicus
WO2007031883A3 (fr) Composition contenant au moins un derive d'acide naphtoique et au moins un compose de type polymere de polyurethane ou des derives de ce compose, procedes de fabrication et utilisations de cette composition
WO2009156675A3 (fr) Nouvelles compositions dépigmentantes sous forme d'une composition anhydre sans vaseline et sans élastomère comprenant un dérivé phénolique solubilisé et un rétinoïde
WO2009027382A3 (fr) Composition pulvérisable contenant de l'extrait de feuille de vigne rouge
EP2065025A3 (fr) Composition de conservation et son utilisation, son procédé de préparation et formulations la contenant

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07766070

Country of ref document: EP

Kind code of ref document: A2

REEP Request for entry into the european phase

Ref document number: 2007766070

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2007766070

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2649124

Country of ref document: CA

NENP Non-entry into the national phase

Ref country code: DE